These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 15356670

  • 1. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
    Coffey CS, Steiner D, Baker BA, Allison DB.
    Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1411-9. PubMed ID: 15356670
    [Abstract] [Full Text] [Related]

  • 2. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
    Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T.
    Int J Obes Relat Metab Disord; 2002 May; 26(5):593-604. PubMed ID: 12032741
    [Abstract] [Full Text] [Related]

  • 3. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
    Kalman D, Incledon T, Gaunaurd I, Schwartz H, Krieger D.
    Int J Obes Relat Metab Disord; 2002 Oct; 26(10):1363-6. PubMed ID: 12355332
    [Abstract] [Full Text] [Related]

  • 4. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
    Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL.
    Int J Obes Relat Metab Disord; 2001 Mar; 25(3):316-24. PubMed ID: 11319627
    [Abstract] [Full Text] [Related]

  • 5. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
    Astrup A, Breum L, Toubro S, Hein P, Quaade F.
    Int J Obes Relat Metab Disord; 1992 Apr; 16(4):269-77. PubMed ID: 1318281
    [Abstract] [Full Text] [Related]

  • 6. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
    Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, Stohs SJ, Stern JS, Keen CL.
    Int J Obes (Lond); 2006 Oct; 30(10):1545-56. PubMed ID: 16552410
    [Abstract] [Full Text] [Related]

  • 7. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
    Preuss HG, DiFerdinando D, Bagchi M, Bagchi D.
    J Med; 2002 Oct; 33(1-4):247-64. PubMed ID: 12939122
    [Abstract] [Full Text] [Related]

  • 8. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
    Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J, RIO-North America Study Group.
    JAMA; 2006 Feb 15; 295(7):761-75. PubMed ID: 16478899
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of a novel herbal formulation for weight management in obese subjects: a randomized double blind placebo controlled clinical study.
    Sengupta K, Mishra AT, Rao MK, Sarma KV, Krishnaraju AV, Trimurtulu G.
    Lipids Health Dis; 2012 Sep 20; 11():122. PubMed ID: 22995673
    [Abstract] [Full Text] [Related]

  • 10. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
    Belza A, Frandsen E, Kondrup J.
    Int J Obes (Lond); 2007 Jan 20; 31(1):121-30. PubMed ID: 16652130
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
    Molnár D, Török K, Erhardt E, Jeges S.
    Int J Obes Relat Metab Disord; 2000 Dec 20; 24(12):1573-8. PubMed ID: 11126208
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of a novel herbal formulation for weight loss demonstrated in a 16-week randomized, double-blind, placebo-controlled clinical trial with healthy overweight adults.
    Dixit K, Kamath DV, Alluri KV, Davis BA.
    Diabetes Obes Metab; 2018 Nov 20; 20(11):2633-2641. PubMed ID: 29923305
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
    Toubro S, Astrup AV, Breum L, Quaade F.
    Int J Obes Relat Metab Disord; 1993 Feb 20; 17 Suppl 1():S69-72. PubMed ID: 8384186
    [Abstract] [Full Text] [Related]

  • 14. Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects.
    Uebelhack R, Bongartz U, Seibt S, Bothe G, Chong PW, De Costa P, Wszelaki N.
    J Obes; 2019 Feb 20; 2019():3412952. PubMed ID: 30863632
    [Abstract] [Full Text] [Related]

  • 15. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition.
    Greenway FL, De Jonge L, Blanchard D, Frisard M, Smith SR.
    Obes Res; 2004 Jul 20; 12(7):1152-7. PubMed ID: 15292480
    [Abstract] [Full Text] [Related]

  • 16. Is an ephedrine caffeine treatment contraindicated in hypertension?
    Ingerslev J, Svendsen TL, Mørk A.
    Int J Obes Relat Metab Disord; 1997 Aug 20; 21(8):666-73. PubMed ID: 15481766
    [Abstract] [Full Text] [Related]

  • 17. Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.
    Ohara T, Muroyama K, Yamamoto Y, Murosaki S.
    Nutr J; 2016 Jan 19; 15():6. PubMed ID: 26786000
    [Abstract] [Full Text] [Related]

  • 18. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial.
    Chanoine JP, Hampl S, Jensen C, Boldrin M, Hauptman J.
    JAMA; 2005 Jun 15; 293(23):2873-83. PubMed ID: 15956632
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
    Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagné J.
    JAMA; 2003 Mar 26; 289(12):1537-45. PubMed ID: 12672771
    [Abstract] [Full Text] [Related]

  • 20. Regular Consumption of Lipigo® Promotes the Reduction of Body Weight and Improves the Rebound Effect of Obese People Undergo a Comprehensive Weight Loss Program.
    Valero-Pérez M, Bermejo LM, López-Plaza B, García MA, Palma-Milla S, Gómez-Candela C.
    Nutrients; 2020 Jun 30; 12(7):. PubMed ID: 32630079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.